Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism - The SWAN Study.
Thomas HendriksScott McGregorShilpa RakeshJulie RobinsonKwok M HoRoss BakerPublished in: PloS one (2020)
Patient satisfaction with anti-Xa direct oral anticoagulant therapy for the treatment and prevention of venous thromboembolism after switching from warfarin in routine clinical practice appeared high. Improved patient convenience including reduced frequency of medical contact and fewer unpredictable side effects were perceived as significant advantages of anti-Xa direct oral anticoagulants compared to warfarin.
Keyphrases
- venous thromboembolism
- direct oral anticoagulants
- patient satisfaction
- clinical practice
- atrial fibrillation
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- healthcare
- physical activity
- mental health
- prognostic factors
- depressive symptoms
- case report
- patient reported outcomes
- smoking cessation